» Articles » PMID: 40032920

Nonlinear Association Between Serum 25-hydroxyvitamin D Concentrations and Lung Function in the United States Adult Population with COPD

Overview
Journal Sci Rep
Specialty Science
Date 2025 Mar 3
PMID 40032920
Authors
Affiliations
Soon will be listed here.
Abstract

Vitamin D has been studied for its potential protective effects against lung function decline in patients with COPD. However, conflicting results exist, the actual effect of vitamin D on lung function remains controversial. This study aimed to determine whether serum 25-hydroxyvitamin D (25-OHD) levels are correlated with lung function in community-dwelling individuals with COPD. We used data from the National Health and Nutrition Examination Survey (NHANES) to explore the relationship between serum 25-OHD concentration and the severity of airflow obstruction. Multivariable logistic regression, stratified analysis with interaction, restricted cubic splines (RCS), and threshold effect analysis were used to investigate the association between serum 25-OHD concentration and lung function.A total of 1384 patients with COPD were analyzed. Accordingly, the association between serum 25-OHD concentrations and lung function exhibited an inverse L-shaped curve in the RCS. Threshold analysis showed that in participants with 25-OHD concentrations < 90 nmol/L, lung function decreased with decrease in serum 25-OHD concentrations, whereas no significant association was observed in those with serum 25-OHD concentrations ≥ 90 nmol/L. An inverse L-shaped relationship was observed between serum 25-OHD concentration and airflow obstruction severity in the adult population with COPD in the United States.

References
1.
Beaudart C, Buckinx F, Rabenda V, Gillain S, Cavalier E, Slomian J . The effects of vitamin D on skeletal muscle strength, muscle mass, and muscle power: a systematic review and meta-analysis of randomized controlled trials. J Clin Endocrinol Metab. 2014; 99(11):4336-45. DOI: 10.1210/jc.2014-1742. View

2.
Agusti A, Faner R . Lung function trajectories in health and disease. Lancet Respir Med. 2019; 7(4):358-364. DOI: 10.1016/S2213-2600(18)30529-0. View

3.
Holick M, Binkley N, Bischoff-Ferrari H, Gordon C, Hanley D, Heaney R . Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011; 96(7):1911-30. DOI: 10.1210/jc.2011-0385. View

4.
Baeke F, Takiishi T, Korf H, Gysemans C, Mathieu C . Vitamin D: modulator of the immune system. Curr Opin Pharmacol. 2010; 10(4):482-96. DOI: 10.1016/j.coph.2010.04.001. View

5.
Sanket S, Madireddi J, Stanley W, Sura P, Prabhu M . Relation between Vitamin D Deficiency and Severity of Chronic Obstructive Pulmonary Disease-A Case Control Study. J Clin Diagn Res. 2016; 10(1):OC16-9. PMC: 4740636. DOI: 10.7860/JCDR/2016/15404.7097. View